[1]
M. Olivola, V. Arienti, N. Bassetti, S. Civardi, and N. Brondino, “Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders: a case report”, EXCLI J., vol. 21, pp. 540–543, Feb. 2022.